amag onepager portfolio 062626020.pptx - read-only€¦ · title: microsoft powerpoint -...
TRANSCRIPT
![Page 1: AMAG OnePager Portfolio 062626020.pptx - Read-Only€¦ · Title: Microsoft PowerPoint - AMAG_OnePager_Portfolio_062626020.pptx - Read-Only Author: MBegley Created Date: 7/9/2020](https://reader034.vdocuments.us/reader034/viewer/2022051916/6008ad7b6f100a50d11218c1/html5/thumbnails/1.jpg)
OUR PORTFOLIO AT A GLANCE
Please see full Prescribing Information at makena.com
1
PHASE 1 PHASE 2 PHASE 3 Regulatory Review
Approved/Marketed
Ciraparantagi
Feraheme® (ferumoxytol injection) Please see full Prescribing Information including Boxed Warning at Feraheme.com
AMAG-423Digoxin Immune Fab (ovine)i
Makena® (hydroxyprogesterone caproate injection)
i. In clinical development; safety and efficacy of the product candidate has not been established.
As of July 2020
© 2019 AMAG Pharmaceuticals, Inc. All rights reserved.
![Page 2: AMAG OnePager Portfolio 062626020.pptx - Read-Only€¦ · Title: Microsoft PowerPoint - AMAG_OnePager_Portfolio_062626020.pptx - Read-Only Author: MBegley Created Date: 7/9/2020](https://reader034.vdocuments.us/reader034/viewer/2022051916/6008ad7b6f100a50d11218c1/html5/thumbnails/2.jpg)
www.amagpharma.com
© 2019 AMAG Pharmaceuticals, Inc. All rights reserved.